BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 12032779)

  • 1. The proto-oncogene c-myc in hematopoietic development and leukemogenesis.
    Hoffman B; Amanullah A; Shafarenko M; Liebermann DA
    Oncogene; 2002 May; 21(21):3414-21. PubMed ID: 12032779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation.
    Amanullah A; Liebermann DA; Hoffman B
    Oncogene; 2002 Feb; 21(10):1600-10. PubMed ID: 11896589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA; Hoffman B
    Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53-independent apoptosis associated with c-Myc-mediated block in myeloid cell differentiation.
    Amanullah A; Liebermann DA; Hoffman B
    Oncogene; 2000 Jun; 19(26):2967-77. PubMed ID: 10871848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proto-oncogene c-myc and apoptosis.
    Hoffman B; Liebermann DA
    Oncogene; 1998 Dec; 17(25):3351-7. PubMed ID: 9916997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.
    Vaqué JP; Fernández-García B; García-Sanz P; Ferrandiz N; Bretones G; Calvo F; Crespo P; Marín MC; León J
    Mol Cancer Res; 2008 Feb; 6(2):325-39. PubMed ID: 18314492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Egr-1 abrogates the E2F-1 block in terminal myeloid differentiation and suppresses leukemia.
    Gibbs JD; Liebermann DA; Hoffman B
    Oncogene; 2008 Jan; 27(1):98-106. PubMed ID: 17599039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade.
    Liebermann DA; Hoffman-Liebermann B
    Oncogene; 1989 May; 4(5):583-92. PubMed ID: 2471131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
    Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
    Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translocations involving c-myc and c-myc function.
    Boxer LM; Dang CV
    Oncogene; 2001 Sep; 20(40):5595-610. PubMed ID: 11607812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Myc is essential for hematopoietic stem cell differentiation and regulates Lin(-)Sca-1(+)c-Kit(-) cell generation through p21.
    Baena E; Ortiz M; Martínez-A C; de Alborán IM
    Exp Hematol; 2007 Sep; 35(9):1333-43. PubMed ID: 17637497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of TRRAP-dependent hTERT and TRRAP-independent CAD activation by Myc/Max contributes to the differentiation of HL60 cells after exposure to DMSO.
    Jiang G; Bi K; Tang T; Wang J; Zhang Y; Zhang W; Ren H; Bai H; Wang Y
    Int Immunopharmacol; 2006 Jul; 6(7):1204-13. PubMed ID: 16714225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking c-Myc and Max expression inhibits proliferation and induces differentiation of normal and leukemic myeloid cells.
    Nguyen HQ; Selvakumaran M; Liebermann DA; Hoffman B
    Oncogene; 1995 Dec; 11(11):2439-44. PubMed ID: 8570196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P; Schmidt M; Hu X; Wolff L
    Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
    Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
    Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the terminal stages of adipocyte differentiation by cMyc.
    Heath VJ; Gillespie DA; Crouch DH
    Exp Cell Res; 2000 Jan; 254(1):91-8. PubMed ID: 10623469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-cycle progression is not essential for c-Myc to block differentiation.
    Ryan KM; Birnie GD
    Oncogene; 1997 Jun; 14(23):2835-43. PubMed ID: 9190900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc.
    Larsson LG; Pettersson M; Oberg F; Nilsson K; Lüscher B
    Oncogene; 1994 Apr; 9(4):1247-52. PubMed ID: 8134128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation.
    Schreiner S; Birke M; García-Cuéllar MP; Zilles O; Greil J; Slany RK
    Cancer Res; 2001 Sep; 61(17):6480-6. PubMed ID: 11522644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways.
    Packham G; Porter CW; Cleveland JL
    Oncogene; 1996 Aug; 13(3):461-9. PubMed ID: 8760287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.